Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy
Age: 18 years - 66+
Gender: All
We've found 2 total result s for "Glomerulonephritis".
This is an open-label Phase 2 study evaluating the long term safety and tolerability of GFB-887 in patients with focal segmental glomerulosclerosis (FSGS), and treatment-resistant minimal change disease (TR-MCD)
Age: 18 - 75 years
Gender: All